Policresulen

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Generic Name
Policresulen
DrugBank Accession Number
DB13492
Background

Not Available

Type
Small Molecule
Groups
Experimental, Investigational
Synonyms
  • Policresulen

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Associated Conditions
Indication TypeIndicationCombined Product DetailsApproval LevelAge GroupPatient CharacteristicsDose Form
Adjunct therapy in treatment ofTrichomonas vaginalis infection•••••••••••••••
Adjunct therapy in treatment ofVaginal infections•••••••••••••••
Associated Therapies
Contraindications & Blackbox Warnings
Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events with our Clinical API
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
See the data
Improve decision support & research outcomes with our structured adverse effects data.
See a data sample
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Products

Drug product information from 10+ global regions
Our datasets provide approved product information including:
dosage, form, labeller, route of administration, and marketing period.
Access now
Access drug product information from over 10 global regions.
Access now
Brand Name Prescription Products
NameDosageStrengthRouteLabellerMarketing StartMarketing EndRegionImage
Jujiafenhuangquan YindaoshuanSuppository90 mg/1UVaginalHeilongjiang Tianlong Pharmaceutical Co Ltd2024-03-01Not applicableUS flag
Jujiafenhuangquan YindaoshuanSuppository1 U/90mgVaginalHeilongjiang Tianlong Pharmaceutical Co Ltd2024-03-01Not applicableUS flag
PolicresulenVaginalSuppositorySolution1 mg/720gBuccal; VaginalHeilongjiang Tianlong Pharmaceutical Co Ltd2024-03-01Not applicableUS flag
Over the Counter Products
NameDosageStrengthRouteLabellerMarketing StartMarketing EndRegionImage
AlbothylLiquid720 mg/1gOralLydia Co., Ltd.2023-01-23Not applicableUS flag
AlbothylSolution720 mg/1mLBuccalOASIS TRADING2018-11-21Not applicableUS flag
ALBOTHYL VAGINAL SUPPOSITORIESSuppository90 mgVaginalTakeda Malaysia Sdn Bhd2020-09-082022-01-14Malaysia flag
ALBOTHYL VAGINAL SUPPOSITORY 90 mgSuppository90 mgVaginalTAKEDA PHARMACEUTICALS (ASIA PACIFIC) PTE. LTD.1989-06-30Not applicableSingapore flag
Jujiafenhuangquan YindaoshuanSuppository1 g/90mgVaginalHeilongjiang Tianlong Pharmaceutical Co Ltd2024-03-06Not applicableUS flag
Mixture Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
FAKTU SUPPOSITORYPolicresulen (100 mg) + Cinchocaine hydrochloride (2.5 mg)SuppositoryRectalTAKEDA PHARMACEUTICALS (ASIA PACIFIC) PTE. LTD.1988-04-26Not applicableSingapore flag
Unapproved/Other Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
AlbothylPolicresulen (720 mg/1g)LiquidOralLydia Co., Ltd.2023-01-23Not applicableUS flag
AlbothylPolicresulen (720 mg/1mL)SolutionBuccalOASIS TRADING2018-11-21Not applicableUS flag
Jujiafenhuangquan YindaoshuanPolicresulen (1 g/90mg)SuppositoryVaginalHeilongjiang Tianlong Pharmaceutical Co Ltd2024-03-06Not applicableUS flag
Jujiafenhuangquan YindaoshuanPolicresulen (90 mg/1U)SuppositoryVaginalHeilongjiang Tianlong Pharmaceutical Co Ltd2024-03-01Not applicableUS flag
Jujiafenhuangquan YindaoshuanPolicresulen (1 U/90mg)SuppositoryVaginalHeilongjiang Tianlong Pharmaceutical Co Ltd2024-03-01Not applicableUS flag

Categories

ATC Codes
D08AE02 — PolicresulenG01AX03 — Policresulen
Drug Categories
Classification
Not classified
Affected organisms
Not Available

Chemical Identifiers

UNII
6I19M5GB0G
CAS number
101418-00-2
InChI Key
Not Available
InChI
Not Available
IUPAC Name
Not Available
SMILES
Not Available

References

General References
  1. DailyMed: Albothyl (policresulen) oral solution [Link]
RxNav
54908
Wikipedia
Policresulen

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
Not AvailableUnknown StatusTreatmentVulva Intraepithelial Nonneoplastic1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
GelVaginal
LiquidOral720 mg/1g
SolutionBuccal720 mg/1mL
SolutionTopical
SuppositoryVaginal
SuppositoryVaginal90 mg
Ointment
SuppositoryRectal2.5 mg
GelVaginal3.6 g
SuppositoryVaginal1 g/90mg
SuppositoryVaginal1 U/90mg
SuppositoryVaginal90 mg/1U
Solution
InsertVaginal100 MG
Solution, concentrate40 %
SolutionBuccal; Vaginal1 mg/720g
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available
Predicted Properties
Not Available
Predicted ADMET Features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
Not Available
Chromatographic Properties
Collision Cross Sections (CCS)
Not Available

Drug created at June 23, 2017 20:43 / Updated at September 28, 2021 21:54